COVID Vaccine Maker Novavax Stock Soars 16% - Here's Why

benzinga.com/25/05/45295534/novavax-reports-q1-profit-as-revenue-surges-to-over-600-million-and-lower-costs-raises-2025-forecasts

On Thursday, Novavax Inc. (NASDAQ:NVAX) reported first-quarter 2025 sales of $667 million, compared to $94 million a year ago, beating the consensus of $343.85 million.
Higher product sales for the first quarter of 2025 were primarily due to $603 million of revenue recognized with the…

This story appeared on benzinga.com, 2025-05-08 17:31:54.
The Entire Business World on a Single Page. Free to Use →